Share
News
-
29 June 2007 /Retail and online sale
Thresholds for the total amount of active substance in certain medicinal products sold in general sales outlets
In Denmark, it is permitted to sell certain over-the-counter medicinal products in non-pharmacy outlets (these products fall within dispensing group HF).
-
19 June 2007 /Authorisation and supervision
New regulations for advanced therapy medicinal products, tissue engineering
The Council and the European Commission have approved a number of new proposals from the European Parliament for a regulation on advanced therapy medicinal products, including 'tissue engineering'.
-
19 June 2007 /Prices and reimbursement
The fixed price system for medicinal products for production animals is abolished
On 2 April 2007, the sale of veterinary medicinal products for production animals became liberaliser. This entails an amendment of a number of executive orders on reporting and notification of information from the retailers to the Danish Medicines Agency in relation to these medicinal products.
-
06 June 2007 /Side effects and trials
The Danish Medicines Agency monitors adverse reactions
During the first two years of a medicinal product's life on the market, adverse reactions are monitored closely. Doctors must report adverse reactions.
-
06 June 2007 /Retail and online sale
Counterfeit versions of the medicinal product Zyprexa® found in Great Britain
The British Medicines and Healthcare products Regulatory Agency (MHRA)today issued a drug alert in response to finding of counterfeit versions of the medicinal product Zyprexa® (olanzapine) 10mg tablets in the UK supply chain.
-
06 June 2007 /Retail and online sale
Counterfeit versions of the medicinal products Plavix® and Casodex@ found in Great Britain
The British Medicines and Healthcare products Regulatory Agency (MHRA) has issued drug alerts in response to findings of counterfeit versions of the medicinal products Plavix® (clopidogrel) 75 mg tablets and Casodex® (bicalutamide) in the UK supply chain.
